CN113671054A - Method for measuring concentration of metolachlor in oral-nasal inhalation toxicant exposure system - Google Patents
Method for measuring concentration of metolachlor in oral-nasal inhalation toxicant exposure system Download PDFInfo
- Publication number
- CN113671054A CN113671054A CN202010405051.8A CN202010405051A CN113671054A CN 113671054 A CN113671054 A CN 113671054A CN 202010405051 A CN202010405051 A CN 202010405051A CN 113671054 A CN113671054 A CN 113671054A
- Authority
- CN
- China
- Prior art keywords
- metolachlor
- concentration
- oral
- sampling
- filter membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WVQBLGZPHOPPFO-UHFFFAOYSA-N 2-chloro-N-(2-ethyl-6-methylphenyl)-N-(1-methoxypropan-2-yl)acetamide Chemical compound CCC1=CC=CC(C)=C1N(C(C)COC)C(=O)CCl WVQBLGZPHOPPFO-UHFFFAOYSA-N 0.000 title claims abstract description 121
- 238000000034 method Methods 0.000 title claims abstract description 39
- 231100000167 toxic agent Toxicity 0.000 title claims abstract description 35
- 239000003440 toxic substance Substances 0.000 title claims abstract description 35
- 238000005070 sampling Methods 0.000 claims abstract description 83
- 239000012528 membrane Substances 0.000 claims abstract description 67
- 238000011109 contamination Methods 0.000 claims abstract description 45
- 239000000443 aerosol Substances 0.000 claims abstract description 36
- 239000000523 sample Substances 0.000 claims abstract description 35
- 239000012488 sample solution Substances 0.000 claims abstract description 34
- 239000002904 solvent Substances 0.000 claims abstract description 23
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 16
- 238000004458 analytical method Methods 0.000 claims abstract description 10
- 238000005303 weighing Methods 0.000 claims abstract description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 51
- 239000000243 solution Substances 0.000 claims description 21
- 238000001514 detection method Methods 0.000 claims description 9
- 239000012086 standard solution Substances 0.000 claims description 8
- 238000009210 therapy by ultrasound Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 239000002033 PVDF binder Substances 0.000 claims description 4
- 235000005687 corn oil Nutrition 0.000 claims description 4
- 239000002285 corn oil Substances 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 4
- 239000003365 glass fiber Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000012417 linear regression Methods 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000010828 elution Methods 0.000 claims description 2
- 238000010829 isocratic elution Methods 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 description 22
- 238000012360 testing method Methods 0.000 description 15
- 238000010790 dilution Methods 0.000 description 14
- 239000012895 dilution Substances 0.000 description 14
- 238000009472 formulation Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000000126 substance Substances 0.000 description 12
- 239000003814 drug Substances 0.000 description 8
- 231100000820 toxicity test Toxicity 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000012377 drug delivery Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000011161 development Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000012470 diluted sample Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- -1 content is 98.4% Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 231100000824 inhalation exposure Toxicity 0.000 description 1
- 231100000016 inhalation toxicity Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N5/00—Analysing materials by weighing, e.g. weighing small particles separated from a gas or liquid
- G01N5/02—Analysing materials by weighing, e.g. weighing small particles separated from a gas or liquid by absorbing or adsorbing components of a material and determining change of weight of the adsorbent, e.g. determining moisture content
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N2030/042—Standards
- G01N2030/047—Standards external
Abstract
The invention discloses a method for measuring the concentration of metolachlor in an oral-nasal inhalation toxicant exposure system. The method comprises the following steps: s1, enabling metolachlor to generate aerosol under an oral-nasal inhalation contamination system, and sampling in the oral-nasal inhalation contamination system by using a filter membrane to obtain a sampling filter membrane; calculating the actual concentration of aerosol in the oral-nasal inhalation contamination system by using a filter membrane weighing method; s2, placing the sampling filter membrane in a solvent to obtain a sampling filter membrane sample solution; s3, carrying out high performance liquid chromatography analysis on the sampling filter membrane sample solution, determining to obtain a peak area, and obtaining the actual concentration of the metolachlor in the sampling filter membrane sample solution by contrasting a peak area-concentration standard curve of the metolachlor; and calculating to obtain the actual concentration of metolachlor in the oral-nasal inhalation contamination system. The method of the invention can accurately and stably detect the actual concentration of the sample in the contamination device.
Description
Technical Field
The invention relates to a method for determining the concentration of metolachlor in an oral-nasal inhalation toxicant exposure system.
Background
With the development of agricultural production, pesticides are widely used because of their remarkable effects of controlling crop pests, removing weeds, increasing the yield of agricultural products, and the like. Metolachlor is a herbicide widely applied to bud amides at present. The toxicological results show that the metolachlor has slight irritation to the skin and eyes of rats after transdermal test, and has lethality after oral test. Thus, prolonged exposure to or inhalation of metolachlor pesticide may cause potential health damage. In order to better understand the health risks of metolachlor, the research on toxicity test of metolachlor is particularly important.
At present, a large number of metolachlor toxicity tests are reported at home and abroad, and the administration modes of the metolachlor toxicity tests are acute oral or transdermal toxicity tests. In the using process of metolachlor, pesticide absorption cannot be avoided. However, there is no research on the inhalation contamination of metolachlor, and the toxicity characteristics thereof are not clear, so the development of an analysis method and the development of an inhalation contamination system are urgently needed.
Studies have shown that there are two main toxicant exposure modes for inhalation toxicity studies: tracheal instillation and dynamic inhalation contamination. The tracheal instillation method is simple, special equipment is not needed, but the experimental animals need to be anesthetized before instillation, and the exposure mode of a human cannot be truly simulated. Therefore, the researchers mostly adopt dynamic inhalation toxicant exposure, which mainly includes oral-nasal inhalation toxicant exposure and systemic exposure inhalation toxicant exposure. For the research of rats, oral and nasal inhalation contamination is mostly adopted, so that the influence on the result caused by the fact that experimental animals lick contaminated substances can be prevented. However, oral-nasal inhalation contamination requires special aerosol generation and related contamination devices, and the difficulty of generating stable aerosol is high, and it is difficult to accurately determine the actual concentration of the sample in the contamination device in the prior art, and it is also difficult to know the actual exposure concentration of the sample in the contamination device of the rat. Therefore, in order to ensure the accuracy and stability of the metolachlor oral-nasal inhalation contamination test, the development of a method for measuring the metolachlor in an oral-nasal inhalation contamination system is urgent.
Disclosure of Invention
The invention provides a method for measuring the concentration of metolachlor in an oral-nasal inhalation contamination system, aiming at solving the defect that the actual concentration of a sample in the oral-nasal inhalation contamination system is difficult to detect accurately in the prior art. The method can accurately and stably detect the actual concentration of the sample in the contamination device, ensure the accuracy and stability of the drug delivery in subsequent animal experiments, and lay the foundation for the metolachlor inhalation contamination toxicity test.
The invention solves the technical problems through the following technical scheme.
The invention provides a method for measuring the concentration of metolachlor in an oral-nasal inhalation toxicant exposure system, which comprises the following steps:
s1, enabling metolachlor to generate aerosol under an oral-nasal inhalation contamination system, and sampling in the oral-nasal inhalation contamination system by using a filter membrane to obtain a sampling filter membrane; calculating the actual concentration of aerosol in the oral-nasal inhalation contamination system by using a filter membrane weighing method;
s2, placing the sampling filter membrane in a solvent to obtain a sampling filter membrane sample solution;
s3, carrying out high performance liquid chromatography analysis on the sampling filter membrane sample solution, determining to obtain a peak area, and obtaining the actual concentration of the metolachlor in the sampling filter membrane sample solution by contrasting a peak area-concentration standard curve of the metolachlor; and calculating to obtain the actual concentration of metolachlor in the oral-nasal inhalation contamination system.
The filter membrane weighing method is a basic method for measuring the mass concentration of particulate matters, samples at a specified flow rate, traps the particulate matters in the air on a high-performance filter membrane, weighs the mass before and after the sampling of the filter membrane, obtains the mass of trapped dust according to the mass difference, and obtains the ratio of the mass of the trapped dust to the amount of sampled air, namely the mass concentration of the dust.
In the invention, a filter membrane weighing method is adopted, sampling is carried out for a certain time according to a certain sampling flow to obtain a sampling filter membrane, the exposure contamination process of a rat in an oral-nasal inhalation contamination system is simulated, and the actual concentration (C) of metolachlor in a sampling filter membrane sample solution can be obtained by calculation after the measurement of high performance liquid chromatography analysis1) The actual concentration of metolachlor in the oronasal inhalation toxicant exposure system (C) can then be calculated by the following formula2)：
Actual concentration C of metolachlor in oral-nasal inhalation toxicant exposure system2Actual concentration C of metolachlor in filter membrane sample solution1X amount of solvent in the sample solution of the sampling filter ÷ (flow rate of sampling x time of sampling).
Wherein the amount of the solvent in the sampling filter sample solution is the amount (in volume unit) of the solvent in the step S2; the sampling flow and the sampling time are the sampling flow and the sampling time of a filter membrane weighing method. Actual concentration C of metolachlor in oral-nasal inhalation toxicant exposure system obtained based on calculation2It is known that the actual exposure concentration of metolachlor is found when rats are inhaled into the toxicant exposure system through mouth and nose.
At S1, the oronasal inhalation toxicant exposure system may be conventional in the art, also known as an animal oronasal inhalation exposure system, such as a single concentration oronasal inhalation toxicant exposure system. The person skilled in the art knows that the theoretical concentration (C) of the aerosol in the oronasal inhalation contamination system can be set by adjusting the instrument parameters in the oronasal inhalation contamination system3). Theoretical concentration (C) of the aerosol3) Preferably 800 to 5000mg/m3More preferably 2000mg/m3。
In the filter membrane weighing method, the actual concentration (C) of the aerosol can be calculated according to the mass of the filter membrane before sampling and the mass of the filter membrane after sampling4) Can be used for verifying the set theoretical concentration C of the aerosol3Whether it is stable and qualified (C)4Is required to be at C3Within. + -. 10%, if this condition is satisfied, the gas can be dissolved according to the set gasTheoretical concentration C of the glue3Proceed to the next operation). Actual concentration of confirmed aerosol (C)4) The qualified sampling filter membrane can be used for measuring the concentration of the metolachlor in a mouth and nose inhalation contamination system. In particular, the actual concentration (C) of the aerosol4) The calculation can be made according to the following formula:
actual concentration C of the aerosol4(mg/m3) (post-sampling filter weight-pre-sampling filter weight) ÷ (sample flow x sample time).
In S1, in the oral-nasal inhalation contamination system, the sampling flow rate is preferably 1-10L/min, such as 4L/min.
In S1, in the oral-nasal inhalation contamination system, the sampling time is preferably 1-10 min, for example, 4 min.
In S1, the material of the filter membrane is preferably glass fiber.
In S1, preferably, the metolachlor solution is aerosolized under the oronasal inhalation toxicant exposure system. The preparation process of the metolachlor solution can be conventional in the field, and the metolachlor solution is generally dissolved in a solvent and then uniformly stirred.
The concentration of the metolachlor solution needs to ensure the accuracy of the concentration of a drug administration preparation (namely the accuracy of the concentration of generated aerosol), so that the concentration of a subsequent sampling filter membrane after passing through the aerosol is ensured. Preferably, the target content (C) of the metolachlor solution6) 0.2% -60%; the percentage is the volume percentage of the metolachlor in the metolachlor solution.
Wherein, the solvent is preferably vegetable oil, more preferably corn oil.
Wherein the stirring time is preferably 30min or more.
At S1, when the actual concentration of aerosol C4And the theoretical concentration C of aerosol3When the error therebetween is within an acceptable range (C)4Is required to be at C3Within ± 10%) of the target concentration of metolachlor (C) in the oronasal inhalation toxicant exposure system5) (it can also be considered that rats are exposed to oronasal inhalationThe target exposure concentration of metolachlor when in an infected system) can be calculated by the following formula:
target concentration C of metolachlor in oral-nasal inhalation toxicant exposure system5(mg/m3) Theoretical concentration of aerosol C3Target content C of x metolachlor solution6。
Wherein the target concentration of metolachlor (C) in the oronasal inhalation toxicant exposure system5) Preferably 4 to 1200mg/m3。
The actual concentration C of the metolachlor in the sample solution of the sampling filter membrane is obtained by the detection method1The actual concentration C of metolachlor in the oral-nasal inhalation contamination system can be obtained2. And the actual concentration C of the metolachlor in the sampling filter membrane sample solution can be determined1And the theoretical concentration C of metolachlor in the sampling filter membrane sample solution7And comparing to verify the feasibility and accuracy of the detection method. Theoretical concentration C of metolachlor in filter membrane sample solution7The calculation can be made by:
theoretical concentration C of metolachlor in filter membrane sample solution7Actual concentration of aerosol C4Target content C of x metolachlor solution6Content of metolachlor raw drug is multiplied by (100-metolachlor raw drug moisture)%.
In the formula, the content of the raw metolachlor is the mass percentage content of the metolachlor in the medicine; the raw material water of metolachlor refers to the mass percentage of water in the medicine.
In S2, the sampling filter may be placed in a container, preferably a reagent container conventional in the art, such as a reagent bottle; the solvent is added after the sampling filter membrane is placed in the container.
In S2, the sampling filter membrane sample solution is generally diluted and filtered, and then subjected to high performance liquid chromatography.
Wherein, the diluted diluent is preferably 60% to 90% methanol, for example 75% methanol. The dilution operation may be performed one or more times.
Wherein, preferably, the diluted solution is subjected to ultrasonic treatment, cooled to room temperature, shaken up and filtered.
The time of the ultrasonic treatment is preferably 3-10 min, for example, 5 min.
Wherein the concentration of the diluted sampling filter membrane sample solution is preferably 6.4-76.8. mu.g/mL.
Wherein the filtration operations and conditions may be conventional in the art. Preferably, the filtration is carried out by using a filter head with the pore diameter of 0.22 μm; the filter head is for example a PVDF filter head; the PVDF filter head is for example a filter head with a diameter of 33mm, manufactured by Millex. The amount of the initial filtrate to be discarded is generally 1 to 5mL, for example, 1 mL.
In S3, preferably, the High Performance Liquid Chromatography (HPLC) method may be conventional in the art.
Wherein, the chromatographic column is preferably a C18 reversed phase chromatographic column; more preferably, the reverse phase chromatography column has a specification of 150 × 4.6mm (length L × inner diameter ID), 5 μm; even more preferably, the reverse phase chromatography column is a Waters X-Bridge C18 chromatography column.
Among them, the elution is preferably performed by isocratic elution.
Wherein the mobile phase is preferably methanol to ultrapure water in a volume ratio of 75: 25.
The detection wavelength is preferably 210-250 nm, such as 230 nm.
Wherein the column temperature is preferably 25 to 30 ℃.
Wherein the sample injector temperature is preferably 2-8 ℃, for example 6 ℃.
Wherein, the flow rate is preferably 0.8-1.2 mL/min, such as 1.0 mL/min.
Wherein the injection volume is preferably 5-20 μ L, such as 10 μ L.
Wherein the operation time is preferably 5min or more, more preferably 8min or more.
In S3, the metolachlor peak area-concentration standard curve can be determined by the conventional method in the field. Generally, the metolachlor standard is dissolved in a proper amount of solvent to prepare a plurality of metolachlor standards with a certain concentration gradientRespectively carrying out high performance liquid chromatography analysis on the sample solutions, and establishing a linear regression equation by using the peak area (Y) of the metolachlor measured in the metolachlor standard solution and the corresponding concentration (X). As known to those skilled in the art, the actual concentration C of metolachlor in the sampling filter membrane sample solution can be obtained by comparing the peak area calculated after the high performance liquid chromatography analysis of the sampling filter membrane sample solution with the peak area-concentration standard curve of metolachlor1And calculating to obtain C2. If the dilution treatment is performed before the high performance liquid chromatography analysis, the dilution factor is multiplied (the dilution factor is the ratio of the concentration of the preparation to the concentration of the diluted sample).
Wherein, the metolachlor standard solution is preferably prepared by dissolving a metolachlor standard in a proper amount of methanol.
Wherein, the concentration of the metolachlor standard solution is preferably 2-100 μ g/mL, such as 2 μ g/mL, 10 μ g/mL, 20 μ g/mL, 50 μ g/mL or 100 μ g/mL.
On the basis of the common knowledge in the field, the above preferred conditions can be combined randomly to obtain the preferred embodiments of the invention.
The reagents and starting materials used in the present invention are commercially available.
The positive progress effects of the invention are as follows:
the method can accurately and stably detect the actual concentration of the sample in the contamination device, ensure the accuracy and stability of the drug delivery in subsequent animal experiments, and lay the foundation for the metolachlor inhalation contamination toxicity test.
The invention reduces the influence of auxiliary materials on sample detection, ensures the feasibility of an oral-nasal inhalation contamination system, can accurately and efficiently detect the concentration of the preparation in a toxicological inhalation drug delivery test, and has the advantages of lower cost, convenient experiment operation, high accuracy, good repeatability, objective result judgment and high sensitivity; has very important significance for the toxicity test research of the pesticide.
Drawings
FIG. 1 is a chromatogram of a diluent alone (75% methanol) excluding the interfering effect of the diluent (75% methanol) on the measurement of a sample.
FIG. 2 is a chromatogram of only the solvent (corn oil) excluding the interfering effect of the solvent on the measurement of the sample.
FIG. 3 is a chromatogram of a solvent sampling filter, which is used for eliminating the interference of the sampling filter and the inhalation contamination system on the tested substance.
Detailed Description
The invention is further illustrated by the following examples, which are not intended to limit the scope of the invention. The experimental methods without specifying specific conditions in the following examples were selected according to the conventional methods and conditions, or according to the commercial instructions.
In the following examples, the "test substance" refers to a sample of metolachlor, which contains 98.4% of metolachlor and 0.1% of water (the percentages are mass percentages); "vehicle" means corn oil.
Example 1: establishment of standard curve for detecting metolachlor by HPLC method
(1) Preparing a standard curve solution (hereinafter referred to as a standard curve solution): precisely transferring 25 mu L of metolachlor standard product (with the purity of 98.543%) into a 25mL volumetric flask, precisely weighing the weight of the transferred volume of metolachlor, adding a certain amount of methanol for dissolving and diluting to a scale to prepare a standard yeast solution stock solution with the concentration of the metolachlor of 0.1% (1.0mg/mL), and diluting into a series of standard yeast solutions with different concentrations of the metolachlor according to the table 1.
Table 1 standard dilution preparation protocol
(2) Determination of Standard Curve
The HPLC analysis method is as follows: using a C18 reverse phase chromatography column (specification 150 × 4.6mm (L × ID), 5 μm, Waters X-Bridge C18 column), purified water in methanol: the ultrapure water is eluted at the same flow rate as 75:25, the detection wavelength is 230nm, the column temperature is 30 ℃, the injector temperature is 6 ℃, the flow rate is 1.0mL/min, the injection volume is 10 mu L, and the running time is 8 min.
The results of the linear regression equation established by taking the peak area (Y) of the metolachlor measured in the standard solution as the ordinate and the corresponding concentration (X) as the abscissa after the samples with various concentrations are measured once respectively, are shown in the table 2, and the metolachlor has good linearity in the concentration range of 2ppm to 100ppm (2 mu g/mL to 100 mu g/mL), and the range is determined to be the detection range of the method.
TABLE 2 results of standard curves
Example 2: preparation of metolachlor administration preparation and verification analysis
(1) Preparation of metolachlor suspension preparation
Proportionally transferring or measuring the required amount of test substance (in which metolachlor is used as test sample, content is 98.4%, and water content is 0.1%) and solvent, stirring for at least 30min, and mixing. The prepared administration preparations are marked by labels with different colors, the solvent chromatogram is shown in figure 2, and the preparation ratios of the administration preparations are shown in table 3.
TABLE 3 formulation of the drug delivery formulations
(2) Drug delivery formulation sample handling
Transferring the proper amount of the high-concentration and low-concentration administration preparation in the step (1) into a volumetric flask with proper specification, adding a proper amount of 75% methanol (the chromatogram of only 75% methanol is shown in figure 1), performing ultrasonic treatment for 5min, cooling to room temperature, fixing the volume to scale, and shaking up. High concentrations still require a second dilution step. And (3) discarding 1mL of primary filtrate by using a filter head with the diameter of 0.22 mu m for the sample solution after shaking up to obtain a sample solution for HPLC analysis, and processing 6 parts in parallel. The sample concentrations after dilution are as in table 4:
TABLE 4 preparation of samples to be tested
(3) Detecting the sample to be detected prepared in the step (2) according to the HPLC detection method in the embodiment 1, respectively measuring corresponding peak areas, substituting the peak areas into a regression equation for calculation to obtain corresponding concentrations, multiplying the corresponding concentrations by a dilution factor, wherein the dilution factor of the low-concentration sample is 100, the dilution factor of the high-concentration sample is 10000, the concentration of the metolachlor suspension preparation can be obtained, and the acceptance standard is that the average recovery rate is 85-115% and the RSD is within 10%. Specific data are shown in table 5, resulting in within-batch precision and accuracy of the administered formulations within acceptable ranges:
TABLE 5 results of precision and accuracy in test substance administration preparation batches
In table 5:
(xiresults of content measurement for six parallel groups of samples);
average recovery (%) — content mean/theoretical content × 100%;
theoretical content of the administered formulation C8Target content of the administered formulation C%)6X content of original drug of test substance x (100-moisture of original drug of test substance)%.
(4) The stability of the metolachlor administration preparation was measured according to the above steps (1), (2) and (3), and the results are shown in Table 6, with the acceptance criterion RD within 5% and the recovery rate within 85% -115%. The result proves that the metolachlor administration preparation is stable within 24 hours at room temperature and 8 days at 2-8 ℃.
TABLE 6 stability results of test substance formulations
In table 6:
(X1for the first measurement of a parallel sample, X2Second measurement of a parallel sample).
Example 3: metolachlor inhalation toxicant aerosol sampling method and verification analysis thereof
(1) Preparation of metolachlor suspension formulations the same as in example 2
(2) Collection of inhaled contaminated aerosol sampling filter membrane
The divided administration preparation is prepared according to the determined concentration parameters (aerosol theoretical concentration C)3＝2000mg/m3) Aerosol occurs under a single concentration oronasal inhalation toxicant exposure system. After the system reaches the set value and is stable, sampling is carried out for 4min by using a filter membrane weighing method (the filter membrane is made of glass fiber materials) according to the sampling flow of 4L/min, the aerosol concentration is measured, after the measured value is qualified (the measured value needs to be +/-10% of the set value), the filter membrane is put into a proper container and is marked by using labels with different colors, the chromatogram of the solvent sampling filter membrane is shown in figure 3, and the set parameters and the target concentration are shown in the following table 7:
actual concentration of Aerosol C4(mg/m3) (post-sampling filter weight-pre-sampling filter weight) ÷ (sample flow x sample time).
Among them, in Table 7, the target concentration C of metolachlor in the oral-nasal inhalation toxicant exposure system5Theoretical concentration of aerosol C3Target content C of x metolachlor solution6。
TABLE 7 inhalation toxicant Aerosol parameter settings
(3) Treatment of filter membrane sample for sampling inhaled contaminated aerosol
Adding a certain amount of 75% methanol into a container equipped with a filter membrane, and performing ultrasonic treatment for 5 min. Cooled to room temperature and shaken up. And if the second step of dilution exists, transferring a proper amount of the first step solution into a volumetric flask with a proper specification, adding 75% methanol for dilution until the volume is constant to a scale, and shaking up to obtain the product. And filtering the finally diluted and uniformly mixed sample solution by using a filter head with the diameter of 0.22 mu m, and discarding 1mL of primary filtrate to obtain the sample solution for HPLC analysis. Wherein, the mass of the sample in the sampling filter membrane is equal to the target concentration C of metolachlor in the oral-nasal inhalation contamination system5(sample exposure concentration) × sampling flow rate × sampling time. The dilution factor is shown in Table 8. For a sampling filter membrane of a low-concentration administration preparation, 10mL of 75% methanol is added in total to obtain a diluted sample to be sampled in the filter membrane; for the high concentration drug delivery formulation, the sample was sampled from the filter after dilution by adding 250mL of 75% methanol.
TABLE 8 sample dilution of the sampling Filter
(4) Detecting the sample to be detected prepared in the step (3) according to the HPLC detection method in the embodiment 1, respectively measuring corresponding peak areas, substituting the peak areas into a regression equation for calculation, and obtaining the actual concentration C of the metolachlor in the corresponding sampling filter membrane1Multiplying the amount of the solvent in the sampling filter membrane sample solution by the amount of the solvent in the sampling filter membrane sample solution of the low-concentration sample, wherein the amount of the solvent in the sampling filter membrane sample solution of the high-concentration sample is 250mL, obtaining the mass of the metolachlor in the sampling filter membrane, dividing the mass by the sampling flow of 4L/min and dividing the sampling flow by the sampling time of 4min, and obtaining the actual concentration C of the metolachlor in an oral-nasal inhalation contamination system2. The acceptance criteria are that the average recovery rate is 70-130% and the RSD is within 10%. Specific data are shown in table 9, resulting in within-batch precision and accuracy of the administered formulations within acceptable ranges:
TABLE 9 test substance dosing formulation sampling Filter Membrane in-batch precision and accuracy results
The theoretical concentration of the metolachlor in the sampling filter membrane (namely the theoretical concentration C of the metolachlor in the oral-nasal inhalation contamination system)7)(mg/m3) Actual concentration of aerosol C4X theoretical content of the administered formulation C8. Wherein the theoretical content C of the preparation to be administered8Target content of the formulation C6X content of original drug of test substance x (100-moisture of original drug of test substance)%.
(5) The stability of the metolachlor inhalation contamination sampling filter membrane was determined according to the above steps (1), (2), (3) and (4), and the results are shown in Table 10, with the acceptance criteria of recovery rate within 70% -130% and RD within 5%. The result proves that the metolachlor is stable in 2 days to 8 ℃ within 24 hours at room temperature after being inhaled into the contamination sampling filter membrane.
TABLE 10 test substance dosing formulation sampling Filter stability results
The above-described specific embodiments are merely preferred embodiments of the present invention, and it should be noted that, for those skilled in the art, various modifications or substitutions can be made without departing from the principle of the present invention, and these modifications or substitutions should also be regarded as the protection scope of the present invention.
Claims (10)
1. The method for measuring the concentration of metolachlor in an oral-nasal inhalation toxicant exposure system is characterized by comprising the following steps of:
s1, enabling metolachlor to generate aerosol under an oral-nasal inhalation contamination system, and sampling in the oral-nasal inhalation contamination system by using a filter membrane to obtain a sampling filter membrane; calculating the actual concentration of aerosol in the oral-nasal inhalation contamination system by using a filter membrane weighing method;
s2, placing the sampling filter membrane in a solvent to obtain a sampling filter membrane sample solution;
s3, carrying out high performance liquid chromatography analysis on the sampling filter membrane sample solution, determining to obtain a peak area, and obtaining the actual concentration of the metolachlor in the sampling filter membrane sample solution by contrasting a peak area-concentration standard curve of the metolachlor; and calculating to obtain the actual concentration of metolachlor in the oral-nasal inhalation contamination system.
2. The method of claim 1 wherein the actual concentration of metolachlor in said oral-nasal inhalation toxicant exposure system is calculated by the formula:
actual concentration C of metolachlor in oral-nasal inhalation toxicant exposure system2Actual concentration C of metolachlor in filter membrane sample solution1X amount of solvent in the sample solution of the sampling filter ÷ (flow rate of sampling x time of sampling).
3. The method of claim 1, wherein in S1, the flow rate of the sample in the oronasal inhalation toxicant exposure system is 1-10L/min, preferably 4L/min;
and/or, in S1, the sampling time is 1-10 min, preferably 4min, in the oral-nasal inhalation contamination system;
and/or, in S1, the material of the filter membrane is glass fiber.
4. The method of determining the concentration of metolachlor in an oronasal inhalation toxicant exposure system of claim 1, wherein, in S1, the metolachlor solution is subjected to aerosol generation under the oronasal inhalation toxicant exposure system; preferably, the metolachlor is dissolved in the solvent and then stirred and mixed uniformly to obtain the metolachlor solution.
5. The method of claim 4, wherein the target concentration of metolachlor in the oral-nasal inhalation toxicant exposure system is 0.2% to 60%; the percentage is the volume percentage of the metolachlor in the metolachlor solution;
and/or the solvent is vegetable oil, preferably corn oil;
and/or the stirring time is more than 30 min.
6. The method of claim 1, wherein the theoretical concentration of aerosol in the oronasal inhalation toxicant exposure system is 800-5000 mg/m3Preferably 2000mg/m3；
And/or, the actual concentration of the aerosol is calculated by the following formula:
actual concentration of aerosol ═ (filter weight after sampling-filter weight before sampling) ÷ (sample flow × sample time);
and/or the target concentration of the metolachlor in the oral-nasal inhalation toxicant exposure system is equal to the theoretical concentration of aerosol x the target content of the metolachlor solution;
and/or the target concentration of metolachlor in the oral-nasal inhalation toxicant exposure system is 4-1200 mg/m3。
7. The method of claim 1, wherein in step S2, the sample solution of the sampling filter is diluted, filtered and analyzed by hplc.
8. The method of claim 7, wherein the concentration of metolachlor in the oral-nasal inhalation toxicant exposure system is determined,
the diluent is 60-90% methanol, preferably 75% methanol;
and/or carrying out ultrasonic treatment on the diluted solution, cooling to room temperature, shaking up and filtering;
wherein the time of the ultrasonic treatment is preferably 3-10 min, for example 5 min;
wherein, the concentration of the diluted sampling filter membrane sample solution is preferably 6.4 to 76.8 mug/mL;
wherein, preferably, the filtration is carried out by a filter head with the pore diameter of 0.22 μm; the filter head is preferably a PVDF filter head; the PVDF filter head is preferably a filter head of Millex manufacturer with a diameter of 33 mm.
9. The method of determining the concentration of metolachlor in an oronasal inhalation toxicant exposure system of claim 1, wherein in S3, the hplc method comprises:
and/or, the chromatographic column is a C18 reverse phase chromatographic column; preferably a Waters X-Bridge C18 chromatography column;
and/or, the specification of the chromatographic column is 150 mm in length multiplied by 4.6mm in inner diameter;
and/or the pore diameter of the chromatographic column is 5 μm;
and/or the elution mode is isocratic elution;
and/or the mobile phase is methanol and ultrapure water in a volume ratio of 75: 25;
and/or the detection wavelength is 210-250 nm, preferably 230 nm;
and/or the column temperature is 25-30 ℃;
and/or the temperature of the sample injector is 2-8 ℃, preferably 6 ℃;
and/or the flow rate is 0.8-1.2 mL/min, preferably 1.0 mL/min;
and/or the sample injection volume is 5-20 muL, preferably 10 muL;
and/or the running time is more than 5min, preferably more than 8 min.
10. The method of claim 1, wherein the metolachlor standard is dissolved in a solvent to prepare a plurality of metolachlor standard solutions with a plurality of concentration gradients, and the solutions are subjected to high performance liquid chromatography, wherein a linear regression equation is established by taking the peak area of the metolachlor in the metolachlor standard solution as an ordinate and the concentration of the metolachlor in the metolachlor standard solution as an abscissa, so as to obtain the standard curve of peak area-concentration of the metolachlor;
preferably, the concentration of the metolachlor standard solution is 2-100 μ g/mL, such as 2 μ g/mL, 10 μ g/mL, 20 μ g/mL, 50 μ g/mL or 100 μ g/mL.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010405051.8A CN113671054A (en) | 2020-05-14 | 2020-05-14 | Method for measuring concentration of metolachlor in oral-nasal inhalation toxicant exposure system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010405051.8A CN113671054A (en) | 2020-05-14 | 2020-05-14 | Method for measuring concentration of metolachlor in oral-nasal inhalation toxicant exposure system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113671054A true CN113671054A (en) | 2021-11-19 |
Family
ID=78537388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010405051.8A Pending CN113671054A (en) | 2020-05-14 | 2020-05-14 | Method for measuring concentration of metolachlor in oral-nasal inhalation toxicant exposure system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113671054A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2037752A1 (en) * | 1990-03-09 | 1991-09-10 | Novartis Ag | Immunological detection of metolachlor |
| WO2005063962A1 (en) * | 2003-12-24 | 2005-07-14 | Drug Risk Solutions, Inc. | System for comminuting, extracting and detecting analytes in sold biological samples |
| CN108414664A (en) * | 2018-04-11 | 2018-08-17 | 国家烟草质量监督检验中心 | A kind of method that ultra high efficiency conjunction phase chromatography-tandem mass spectrum technology splits, measures Chiral pesticide isopropyl methoxalamine enantiomer |
-
2020
- 2020-05-14 CN CN202010405051.8A patent/CN113671054A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2037752A1 (en) * | 1990-03-09 | 1991-09-10 | Novartis Ag | Immunological detection of metolachlor |
| WO2005063962A1 (en) * | 2003-12-24 | 2005-07-14 | Drug Risk Solutions, Inc. | System for comminuting, extracting and detecting analytes in sold biological samples |
| CN108414664A (en) * | 2018-04-11 | 2018-08-17 | 国家烟草质量监督检验中心 | A kind of method that ultra high efficiency conjunction phase chromatography-tandem mass spectrum technology splits, measures Chiral pesticide isopropyl methoxalamine enantiomer |
Non-Patent Citations (5)
| Title |
|---|
| LARRY JK 等: "Inriltration and adsorption of dissolved metolachlor，metolachlor oxanilic acid，and metolachlor ethanesulfonic acid by buffalograss（Buchloe dactyloides）filter strips", 《WEED SCIENCE》 * |
| 周宁: "15％伏草星颗粒剂高效液相色谱测定", 《农药》 * |
| 徐永 等: "苄嘧磺隆-异丙甲草胺混剂的HPLC分析", 《农药》 * |
| 李军德 等: "高效液相色谱法同时检测秸秆饲料中异丙草胺和异丙甲草胺的含量", 《饲料工业》 * |
| 王二琼 等: "40%喹草酮·异丙甲草胺悬浮乳剂的反相高效液相色谱测定", 《安徽化工》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104939831B (en) | The system and method and application thereof of sample are collected from the expiratory air of subject | |
| CN111308002A (en) | Method for detecting isoxazoline insecticide and impurities thereof | |
| CN107315059A (en) | The content assaying method of rifampin and its impurity in a kind of rifampicin capsules | |
| CN113671054A (en) | Method for measuring concentration of metolachlor in oral-nasal inhalation toxicant exposure system | |
| CN110068623B (en) | Method for detecting related substances in imidafenacin | |
| CN106093268A (en) | A kind of detection method of Amitraz content | |
| Harper | Assessing workplace chemical exposures: the role of exposure monitoring | |
| CN115372522A (en) | Method for detecting content of abiraterone acetate | |
| CN107966506B (en) | The detection method of N-ethylaniline content in a kind of Rubber & Rubber Products | |
| CN106525994A (en) | Method for determination of related substances of paracetamol and tramadol hydrochloride capsules | |
| CN105548393A (en) | Method for detecting content of impurity in apremilast raw material | |
| CN112834640B (en) | Method for separating and detecting components in permethrin | |
| CN113519508B (en) | Atrazine suspension, preparation method thereof and high performance liquid chromatography detection method | |
| CN103175906B (en) | Qualitative and quantitative detection method for each component of validamycin | |
| CN110568109A (en) | Method for screening radix peucedani feeding materials in lung ventilating and regulating preparation by adopting HPLC (high performance liquid chromatography) | |
| Kulkarni et al. | ANALYTICAL METHOD EVELOPMENT AND VALIDATION FOR ANTI ASTHAMATIC DRUG OXYMETAZOLINE HYDROCHLORIDE IN NASAL SPRAY FORMULATIONS BY RP-HPLC | |
| CN106404935A (en) | Method for detecting EC content in tea polyphenols | |
| CN112326846A (en) | Method for detecting content of baicalin in children's radix bupleuri and cassia twig antipyretic granules by using HPLC method | |
| CN109444291A (en) | A kind of detection method of content of 1- (4- chlorphenyl) -3- (2,6- difluoro benzoyl) urea | |
| CN103364517A (en) | Analysis method for contents of active components in benthiavalicarb.isopropyl-dimethomorph compound preparation | |
| Hurtt et al. | Ten-day repeated-exposure inhalation study of dimethylformamide (DMF) in cynomolgus monkeys | |
| CN2899734Y (en) | Movable contamination test device realtime controlled by photoelectric detection | |
| CN111337599A (en) | Pretreatment method, morphine detection method and application | |
| CN104251808A (en) | High-accuracy PM2.5 detector | |
| CN104316482A (en) | A quality control method for ambroxol hydrochloride particles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211119 |
|
| RJ01 | Rejection of invention patent application after publication |